blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3431590

EP3431590 - METHOD FOR PRODUCING ACTIVATED HEPATOCYTE GROWTH FACTOR (HGF) [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.06.2022
Database last updated on 28.06.2024
FormerThe patent has been granted
Status updated on  25.06.2021
FormerGrant of patent is intended
Status updated on  27.04.2021
FormerRequest for examination was made
Status updated on  16.10.2020
FormerGrant of patent is intended
Status updated on  27.08.2020
FormerRequest for examination was made
Status updated on  21.12.2018
FormerThe international publication has been made
Status updated on  22.09.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024 [2024/29]
Applicant(s)For all designated states
Eisai R&D Management Co., Ltd.
6-10, Koishikawa 4-chome
Bunkyo-ku
Tokyo 112-8088 / JP
[N/P]
Former [2019/04]For all designated states
Eisai R&D Management Co., Ltd.
6-10, Koishikawa 4-chome Bunkyo-ku
Tokyo 112-8088 / JP
Inventor(s)01 / SHIMIZU, Masashi
c/o Eisai Co. Ltd.
Tsukuba Research Laboratories
5-1-3 Tokodai
Tsukuba-shi Ibaraki 300-2635 / JP
02 / SATO, Toshitaka
c/o KAN Research Institute Inc. 6-8-2
Minatojima-minamimachi
Chuo-ku
Kobe-shi Hyogo 6500047 / JP
03 / ARITA, Yoshihisa
c/o KAN Research Institute Inc. 6-8-2
Minatojima-minamimachi
Chuo-ku
Kobe-shi Hyogo 6500047 / JP
 [2019/04]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2019/04]
Application number, filing date17766718.515.03.2017
[2019/04]
WO2017JP10355
Priority number, dateJP2016005412817.03.2016         Original published format: JP 2016054128
[2019/04]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017159722
Date:21.09.2017
Language:JA
[2017/38]
Type: A1 Application with search report 
No.:EP3431590
Date:23.01.2019
Language:EN
[2019/04]
Type: B1 Patent specification 
No.:EP3431590
Date:28.07.2021
Language:EN
[2021/30]
Search report(s)International search report - published on:JP21.09.2017
(Supplementary) European search report - dispatched on:EP22.10.2019
ClassificationIPC:C12N9/64, C12N5/10, C12N15/09, C12P21/02
[2019/04]
CPC:
C12N9/6424 (EP); C12N9/64 (EP,IL,KR,RU,US); C07K14/4753 (IL,KR,RU,US);
C12N15/09 (EP,IL,RU,US); C12N5/10 (EP,IL,RU,US); C12N9/96 (IL,RU);
C12P21/02 (IL,KR,RU,US); C12Y304/21034 (IL,KR); C12Y304/21073 (IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/04]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON AKTIVIERTEM HEPATOZYTENWACHSTUMSFAKTOR (HGF)[2019/04]
English:METHOD FOR PRODUCING ACTIVATED HEPATOCYTE GROWTH FACTOR (HGF)[2019/04]
French:PROCÉDÉ DE PRODUCTION D'UN FACTEUR DE CROISSANCE HÉPATOCYTAIRE (HGF) ACTIVÉ[2019/04]
Entry into regional phase22.08.2018Translation filed 
22.08.2018National basic fee paid 
22.08.2018Search fee paid 
22.08.2018Designation fee(s) paid 
22.08.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
22.08.2018Examination requested  [2019/04]
22.11.2019Amendment by applicant (claims and/or description)
28.08.2020Communication of intention to grant the patent
14.10.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
28.04.2021Communication of intention to grant the patent
18.06.2021Fee for grant paid
18.06.2021Fee for publishing/printing paid
18.06.2021Receipt of the translation of the claim(s)
Opposition(s)29.04.2022No opposition filed within time limit [2022/27]
Fees paidRenewal fee
26.03.2019Renewal fee patent year 03
24.03.2020Renewal fee patent year 04
23.03.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL28.07.2021
CY28.07.2021
CZ28.07.2021
EE28.07.2021
FI28.07.2021
HR28.07.2021
LV28.07.2021
MC28.07.2021
MK28.07.2021
PL28.07.2021
RO28.07.2021
RS28.07.2021
SI28.07.2021
SK28.07.2021
SM28.07.2021
TR28.07.2021
BG28.10.2021
NO28.10.2021
GR29.10.2021
IS28.11.2021
PT29.11.2021
LU15.03.2022
[2024/29]
Former [2024/23]AL28.07.2021
CY28.07.2021
CZ28.07.2021
EE28.07.2021
FI28.07.2021
HR28.07.2021
LV28.07.2021
MC28.07.2021
MK28.07.2021
PL28.07.2021
RO28.07.2021
RS28.07.2021
SI28.07.2021
SK28.07.2021
SM28.07.2021
BG28.10.2021
NO28.10.2021
GR29.10.2021
IS28.11.2021
PT29.11.2021
LU15.03.2022
Former [2024/20]AL28.07.2021
CY28.07.2021
CZ28.07.2021
EE28.07.2021
FI28.07.2021
HR28.07.2021
LV28.07.2021
MC28.07.2021
PL28.07.2021
RO28.07.2021
RS28.07.2021
SI28.07.2021
SK28.07.2021
SM28.07.2021
BG28.10.2021
NO28.10.2021
GR29.10.2021
IS28.11.2021
PT29.11.2021
LU15.03.2022
Former [2023/08]AL28.07.2021
CZ28.07.2021
EE28.07.2021
FI28.07.2021
HR28.07.2021
LV28.07.2021
MC28.07.2021
PL28.07.2021
RO28.07.2021
RS28.07.2021
SI28.07.2021
SK28.07.2021
SM28.07.2021
BG28.10.2021
NO28.10.2021
GR29.10.2021
IS28.11.2021
PT29.11.2021
LU15.03.2022
Former [2022/47]AL28.07.2021
CZ28.07.2021
EE28.07.2021
FI28.07.2021
HR28.07.2021
LV28.07.2021
MC28.07.2021
PL28.07.2021
RO28.07.2021
RS28.07.2021
SI28.07.2021
SK28.07.2021
SM28.07.2021
BG28.10.2021
NO28.10.2021
GR29.10.2021
IS28.11.2021
PT29.11.2021
Former [2022/29]AL28.07.2021
CZ28.07.2021
EE28.07.2021
FI28.07.2021
HR28.07.2021
LV28.07.2021
PL28.07.2021
RO28.07.2021
RS28.07.2021
SI28.07.2021
SK28.07.2021
SM28.07.2021
BG28.10.2021
NO28.10.2021
GR29.10.2021
IS28.11.2021
PT29.11.2021
Former [2022/25]CZ28.07.2021
EE28.07.2021
FI28.07.2021
HR28.07.2021
LV28.07.2021
PL28.07.2021
RO28.07.2021
RS28.07.2021
SK28.07.2021
SM28.07.2021
BG28.10.2021
NO28.10.2021
GR29.10.2021
IS28.11.2021
PT29.11.2021
Former [2022/24]CZ28.07.2021
EE28.07.2021
FI28.07.2021
HR28.07.2021
LV28.07.2021
PL28.07.2021
RO28.07.2021
RS28.07.2021
SK28.07.2021
BG28.10.2021
NO28.10.2021
GR29.10.2021
IS28.11.2021
PT29.11.2021
Former [2022/11]FI28.07.2021
HR28.07.2021
LV28.07.2021
PL28.07.2021
RS28.07.2021
BG28.10.2021
NO28.10.2021
GR29.10.2021
IS28.11.2021
PT29.11.2021
Former [2022/09]FI28.07.2021
RS28.07.2021
BG28.10.2021
NO28.10.2021
PT29.11.2021
Former [2022/07]NO28.10.2021
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[XA]JPH05103670  (MITSUBISHI CHEM IND) [X] 9-13 * , paragraphs [0009] to [0015], [0018] to [0020] (Family: none) * [A] 1-8;
 [A]JPH06153966  (MITSUBISHI CHEM IND) [A] 1-13 * , claims; example 7 & US 5466593 A claims; example 7 & EP 596524 A2 *;
 [A]JP2002356500  (MITSUBISHI CHEM CORP) [A] 1-13 * , paragraphs [0068] to [0072] & US 2002/0165362 A1 paragraphs [0140] to [0145] & EP 1213302 A1 *;
 [A]  - KIRCHHOFER, D. et al., "Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1", J. Biol. Chem., (20030000), vol. 278, no. 38, ISSN 0021-9258, pages 36341 - 36349, XP002352472 [A] 1-13 * , particularly, p.36342(Cloning, Expression, and Purification of HGFA) *

DOI:   http://dx.doi.org/10.1074/jbc.M304643200
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.